The company stated that the likelihood of someone getting ill "is expected to be rare, but the remote risk of contracting a patient cannot be ruled out." Milan added that he did not receive any reports of adverse events related to this particular batch by Friday's announcement.
Milan refused to provide additional information about the product or the foreign substance.
The voluntary download includes one batch of bottles, each containing 500 0.5 mg tablets, which were distributed in the United States between July and August. The batch number affected is 8082708 and the expiration date is set to September 2020.